|
Volumn 56, Issue 1, 2004, Pages 16-20
|
Influenza vaccination of patients with systemic lupus erythematosus
|
Author keywords
Antibody response; Antinuclear autoantibodies; Hemagglutination inhibition assay; Influenza vaccination; Systemic lupus erythematosus
|
Indexed keywords
ANTIMALARIAL AGENT;
ANTINUCLEAR ANTIBODY;
AUTOANTIBODY;
CYCLOPHOSPHAMIDE;
DANAZOL;
DNA ANTIBODY;
DOUBLE STRANDED DNA;
INFLUENZA VACCINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PREDNISONE;
ADULT;
ANTIBODY TITER;
ARTHRALGIA;
ARTICLE;
CLINICAL ARTICLE;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
CONTROLLED STUDY;
DISEASE ACTIVITY;
DRUG SAFETY;
FEMALE;
FLU LIKE SYNDROME;
GLOMERULONEPHRITIS;
HEMAGGLUTINATION INHIBITION TEST;
HEMOLYTIC ANEMIA;
HUMAN;
IMMUNOGENICITY;
INFLUENZA;
INFLUENZA VACCINATION;
INJECTION PAIN;
INJECTION SITE;
PANCYTOPENIA;
STATISTICAL ANALYSIS;
STATISTICAL SIGNIFICANCE;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ADULT;
ANTIBODIES, ANTINUCLEAR;
AUTOANTIBODIES;
FEMALE;
FOLLOW-UP STUDIES;
HEMAGGLUTINATION INHIBITION TESTS;
HUMANS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
|
EID: 2342420522
PISSN: 00348376
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (47)
|
References (10)
|